Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Journal of Translational Medicine|January 14, 2025
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosisMariarita Spampinato, Cesarina Giallongo, Sebastiano Giallongo, et al.
The Lancet. Oncology|September 26, 2015
Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort studyFabio Efficace, Gianluca Gaidano, Massimo Breccia, et al.
Oncogenesis|January 22, 2022
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironmentCesarina Giallongo, Ilaria Dulcamare, Daniele Tibullo, et al.
Leukemia|February 23, 2020
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS indexFabio Efficace, Francesco Cottone, Laura B Oswald, et al.
Cancer|December 13, 2017
Patient-reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromesFabio Efficace, Francesco Cottone, Gregory Abel, et al.
Cancer Medicine|January 28, 2023
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA ProjectGiacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, et al.
British Journal of Haematology|February 5, 2020
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet countsHaifa Kathrin Al-Ali, Martin Griesshammer, Lynda Foltz, et al.
Hemasphere|March 25, 2025
Patient and physician perceptions regarding treatment expectations and symptomatology in polycythemia vera: Insights from the Landmark 2.0 global health surveyClaire N Harrison, David M Ross, Laura Maria Fogliatto, et al.
Cancers|May 13, 2023
Azacitidine Post-Remission Therapy for Elderly Patients with AML: A Randomized Phase-3 Trial (QoLESS AZA-AMLE)Esther Natalie Oliva, Anna Candoni, Prassede Salutari, et al.
British Journal of Haematology|October 2, 2014
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromesFabio Efficace, Gianluca Gaidano, Massimo Breccia, et al.
Pageof 12